News & Insights

Urine Drugs of Abuse Programme is now UKAS ISO 17043 Accredited

We are proud to announce that our Urine Drugs of Abuse Programme is now ISO 17043 accredited.  Please click on the link below to download our poster recently presented at EuroMedLab in Athens.

Continue Reading →

New Enrolment 2017-2018

Weqas 2017-2018 is now available. Click on the link to request a document.

Continue Reading →

Waters TQ-XS Triple Quadrupole Mass Spectrometer

We have just taken delivery of a new Waters TQ-XS Triple Quadrupole Mass Spectrometer, coupled to an ACQUITY UPLC System with 2D LC Technology. The Weqas Reference Laboratory is the first clinical laboratory to have this Waters flagship instrument in the UK. Such an exciting acquisition will enable the Reference Laboratory to offer additional Reference

Continue Reading →

non-HDL Cholesterol

Weqas will be offering non-HDL Cholesterol as a new analyte as part of the Lipids programme. This will take effect from September distribution.    

Continue Reading →

Weqas launches pilot EQA Programme for Quantitative FIT

Weqas have been offering a FOB and FIT Qualitative Programme since July 2014 and successfully gained ISO 17043 accreditation in February 2016.  Following on from this success, Weqas has developed the programme further and will be offering a Quantitative FIT Programme free of charge to UK customers (postage may be charged to overseas customers), during

Continue Reading →

Serum Indices Programme

The Serum Indices programme has now been added to the Weqas interactive site. Currently (distribution IQQ) result entry and reports will only be available online. The latest serum Indices distribution (IQN), was the first trial of electronic reporting and has recently been released.    Serum Indices Programme

Continue Reading →

Weqas EQA Results Processing

From July 15th, we will no longer be processing Weqas EQA results received via post, fax or email. From this date, all results must be entered electronically by participants via the Weqas interactive user account: If you do not already have a Weqas interactive user account, please download the Weqas Interactive form via the following

Continue Reading →

HbA1c EQA Programme- new changes

The Weqas programme has been recently modified to predominantly distribute patient samples. Glycated Haemoglobin (HbA1c) is an established test for monitoring diabetic control and is recommended by the World Health Organisation for the diagnosis of Diabetes Mellitus, provided that stringent quality assurance tests are in place and assays are standardised to criteria aligned to the international reference values

Continue Reading →

New Co-oximetry Vials

New vials for Weqas Co-oximetry scheme were recently introduced to overcome numerous issues with the previous design. We welcome your feedback on this design modification. To view a demonstration on how to use these vials, please use the link:

Continue Reading →

New POCT INR EQA Quality Controls

WEQAS has recently introduced a new Point of Care (POC) INR EQA control, suitable for use with the Abbott i-STAT, Roche CoaguChek XS, XS Plus & XS Pro and Siemens Xprecia Stride instruments. Point of care (POC, or near patient) testing for measurement of the international normalized ratio (INR) is extensively used for self-monitoring of

Continue Reading →

Upcoming Events

  1. IBMS- Birmingham

    September 24 @ 9:00 am - September 27 @ 5:00 pm